Hospital Care

Advanced Molecular Testing for Central Nervous System Infections

Rapid and accurate identification of pathogens responsible for meningitis and encephalitis is critical for supporting timely clinical decisions and effective patient management. R-Biopharm Australia’s syndromic multiplex PCR solutions enable clinical laboratories to detect a broad range of bacterial, viral and fungal targets from cerebrospinal fluid samples, helping streamline diagnostic workflows and improve confidence in results.

Designed for modern molecular diagnostic laboratories, our solutions provide comprehensive pathogen detection from a single sample, reducing the need for multiple individual tests. Supported by trusted global technology and local expertise, R-Biopharm Australia helps laboratories deliver reliable diagnostic insights when rapid decision-making is essential.

a woman in a lab coat, hairnet and gloves conducting a test for meningitis or similar illnesses

three complex medical diagnostic instruments arranged together on a transparent background